Search

everythinglearnresearchcommunity

for

Search:↓

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Iraqi women with PCOS often have higher testosterone levels and obesity.